New Stock Analysis | The track of rising volume and price and the fragile profit structure: How valuable is Sturgeon Technology, the "first stock of Hong Kong black gold"?
Dual narrative of dominant market share and structural concerns.
On June 14th, Hangzhou Qiandaohu Xunlong Technology Co., Ltd. (referred to as Xunlong Technology) successfully underwent a listing hearing on the Main Board of the Hong Kong Stock Exchange, with CITIC SEC and China Securities Co., Ltd. International serving as joint sponsors.
As the world's largest caviar company, Xunlong Technology has built a high industry barrier with over twenty years of full industry chain cultivation. According to Zhoushi Consulting data, the company has been the global leader in caviar sales for 11 consecutive years since 2015, with a global market share expected to rise to 36.1% by 2025, surpassing the second-largest company by more than four times. Despite the impressive achievements, Xunlong Technology also faces growth concerns.
Behind the high performance: overseas dependence and "black box" biological assets
Under the "world's largest caviar company" label, its complex financial structure and potential operational risks are becoming the core battleground for capital market pricing.
On the surface, Xunlong Technology shows a stable growth trend. From 2023 to 2025, the company's revenue increased from 577 million yuan to 769 million yuan, and net profit attributable to equity holders rose from 273 million yuan to 365 million yuan. However, a deeper analysis of its financial structure reveals two prominent structural risks:
Firstly, the high dependence on overseas markets weakens its risk resistance. In 2025, the company's overseas sales accounted for 83.8%, while domestic revenue shrank to 125 million yuan, accounting for only 16.2%. This extremely outward-oriented business model exposes it deeply to various external risks, such as global economic cycles, geopolitical tensions, tariff barriers, and exchange rate fluctuations. Once overseas demand is hindered or trade conditions deteriorate, the domestic market may not provide effective performance buffering.
Secondly, there is a "black box" in the valuation of biological assets, and the main business's profit is fragile. Due to the long breeding cycle of sturgeons, the company's biological asset size has expanded from 1.389 billion yuan to 1.749 billion yuan, accounting for over half of total assets. These assets are measured at fair value, and their value fluctuations directly impact the profit and loss statement.
It is worth noting that despite the profit and loss statement being affected by fair value disturbances, the company demonstrates stron...
Related Articles

From the frenzy on the dark market to the hard work on entering the main market: CREALITY (03388) is holding its ground in the horizontal market.

Hong Kong student dormitory operator Student Living EduVation (SDLV.US) raises fundraising target to $31 million IPO price $4-6 per share.

One picture understanding the Hong Kong Stock Exchange IPO of LB Pharmaceuticals (09637)
From the frenzy on the dark market to the hard work on entering the main market: CREALITY (03388) is holding its ground in the horizontal market.

Hong Kong student dormitory operator Student Living EduVation (SDLV.US) raises fundraising target to $31 million IPO price $4-6 per share.

One picture understanding the Hong Kong Stock Exchange IPO of LB Pharmaceuticals (09637)

RECOMMEND





